Our results point to the usefulness of NTPDase2 as a marker of tumor invasion in EC, especially in cases in which EC coexists with other endometrial disorders, such as adenomyosis, which occasionally hampers the assessment of parameters of tumor invasion [58]. The gene discussed is ENTPD2; the disease is adenomyosis.